SCHEMBL7933437

SCHEMBL7933437

O=C(O)CCCCCC(=O)Nc1nc(CN2CCOCC2)cs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
PDE5A O76074 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE1C Q14123 1/20 0.46
KMT2A Q03164 2/20 0.45
EGFR P00533 2/20 0.44
DHFR P00374 1/20 0.44
LMNA P02545 4/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 2/20 0.44
ADRB2 P07550 1/20 0.44
ERBB3 P21860 1/20 0.43
TSHR P16473 2/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
HDAC3 O15379 2/20 0.42
HDAC4 P56524 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL465800 0.83 SMN1; SMN2 (0.56) POLBSMN1; SMN2KMT2AEGFRDHFR
SCHEMBL3235100 0.81 HDAC3 (0.62) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL7934041 0.78 POLB (0.60) POLBPDE5APDE1APDE1BPDE1C
SCHEMBL465864 0.74 SIRT1 (0.54) POLBSMN1; SMN2KMT2AEGFRDHFR
SCHEMBL6183627 0.72 GAA (0.52) SMN1; SMN2KMT2ALMNAMEN1MAPT
SCHEMBL998227 0.72 SMN1; SMN2 (0.45) POLBSMN1; SMN2KMT2AEGFRDHFR
SCHEMBL12631198 0.72 SMN1; SMN2 (0.60) SMN1; SMN2HTTMAPT
SCHEMBL7924468 0.72 POLB (0.58) POLBPDE5ASMN1; SMN2LMNAMAPK1
SCHEMBL741687 0.71 SMN1; SMN2 (0.58) SMN1; SMN2HTTMAPT
SCHEMBL3262614 0.70 HDAC3 (0.50) HDAC3HDAC1HDAC2HDAC10HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 WO disclosed